nodes	percent_of_prediction	percent_of_DWPC	metapath
Clenbuterol—NGF—atopic dermatitis	0.77	0.838	CbGaD
Clenbuterol—TNF—atopic dermatitis	0.149	0.162	CbGaD
Clenbuterol—TNF—Regulation of toll-like receptor signaling pathway—CASP8—atopic dermatitis	0.000101	0.00127	CbGpPWpGaD
Clenbuterol—TNF—Vitamin B12 Metabolism—IL6—atopic dermatitis	0.0001	0.00125	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—CCL11—atopic dermatitis	9.96e-05	0.00124	CbGpPWpGaD
Clenbuterol—TNF—Toll-like Receptor Signaling Pathway—IL1B—atopic dermatitis	9.86e-05	0.00123	CbGpPWpGaD
Clenbuterol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	9.85e-05	0.00123	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CCL11—atopic dermatitis	9.84e-05	0.00123	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CMA1—atopic dermatitis	9.84e-05	0.00123	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—IFNG—atopic dermatitis	9.83e-05	0.00123	CbGpPWpGaD
Clenbuterol—TNF—TNF alpha Signaling Pathway—MAPK8—atopic dermatitis	9.82e-05	0.00122	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—CCL11—atopic dermatitis	9.75e-05	0.00122	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—CXCL10—atopic dermatitis	9.67e-05	0.00121	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	9.51e-05	0.00119	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	9.51e-05	0.00119	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	9.32e-05	0.00116	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	9.3e-05	0.00116	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	9.3e-05	0.00116	CbGpPWpGaD
Clenbuterol—TNF—Apoptosis—CASP8—atopic dermatitis	9.3e-05	0.00116	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—STAT6—atopic dermatitis	9.25e-05	0.00115	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—CXCL8—atopic dermatitis	9.14e-05	0.00114	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	9.12e-05	0.00114	CbGpPWpGaD
Clenbuterol—TNF—Toll-like Receptor Signaling Pathway—MAPK8—atopic dermatitis	9.04e-05	0.00113	CbGpPWpGaD
Clenbuterol—NGF—NGF signalling via TRKA from the plasma membrane—IL6—atopic dermatitis	9.03e-05	0.00113	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—IL1B—atopic dermatitis	8.77e-05	0.00109	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—IL2—atopic dermatitis	8.74e-05	0.00109	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	8.72e-05	0.00109	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—CASP8—atopic dermatitis	8.72e-05	0.00109	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—CCL11—atopic dermatitis	8.62e-05	0.00107	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—FCER2—atopic dermatitis	8.5e-05	0.00106	CbGpPWpGaD
Clenbuterol—CYP1A1—PPARA activates gene expression—PPARA—atopic dermatitis	8.42e-05	0.00105	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—CCL5—atopic dermatitis	8.32e-05	0.00104	CbGpPWpGaD
Clenbuterol—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARA—atopic dermatitis	8.24e-05	0.00103	CbGpPWpGaD
Clenbuterol—TNF—Folate Metabolism—IL6—atopic dermatitis	8.18e-05	0.00102	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—CCR3—atopic dermatitis	8.12e-05	0.00101	CbGpPWpGaD
Clenbuterol—TNF—Regulation of toll-like receptor signaling pathway—CXCL8—atopic dermatitis	8.02e-05	0.001	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CCR3—atopic dermatitis	8.02e-05	0.001	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—CCR3—atopic dermatitis	7.95e-05	0.000991	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CCL22—atopic dermatitis	7.94e-05	0.00099	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CCL22—atopic dermatitis	7.9e-05	0.000985	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	7.87e-05	0.000982	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—CCL27—atopic dermatitis	7.79e-05	0.000972	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CCL22—atopic dermatitis	7.76e-05	0.000969	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—CCR3—atopic dermatitis	7.73e-05	0.000965	CbGpPWpGaD
Clenbuterol—TNF—Regulation of toll-like receptor signaling pathway—IL1B—atopic dermatitis	7.7e-05	0.00096	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—CCL27—atopic dermatitis	7.62e-05	0.000951	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	7.54e-05	0.00094	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—CCR5—atopic dermatitis	7.5e-05	0.000936	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor—TNF—atopic dermatitis	7.42e-05	0.000926	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—atopic dermatitis	7.42e-05	0.000926	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	7.37e-05	0.00092	CbGpPWpGaD
Clenbuterol—TNF—SIDS Susceptibility Pathways—CXCL8—atopic dermatitis	7.31e-05	0.000913	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—atopic dermatitis	7.31e-05	0.000912	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—NPS—atopic dermatitis	7.24e-05	0.000903	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—TAC1—atopic dermatitis	7.24e-05	0.000903	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—TAC1—atopic dermatitis	7.15e-05	0.000892	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—NPS—atopic dermatitis	7.15e-05	0.000892	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—CXCR3—atopic dermatitis	7.1e-05	0.000886	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—NPS—atopic dermatitis	7.08e-05	0.000884	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—TAC1—atopic dermatitis	7.08e-05	0.000884	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CCL27—atopic dermatitis	7.07e-05	0.000883	CbGpPWpGaD
Clenbuterol—TNF—Regulation of toll-like receptor signaling pathway—MAPK8—atopic dermatitis	7.06e-05	0.00088	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CCL27—atopic dermatitis	7.04e-05	0.000878	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—CCR3—atopic dermatitis	7.02e-05	0.000876	CbGpPWpGaD
Clenbuterol—TNF—SIDS Susceptibility Pathways—IL1B—atopic dermatitis	7.02e-05	0.000875	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CXCR3—atopic dermatitis	7.01e-05	0.000875	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	6.97e-05	0.000869	CbGpPWpGaD
Clenbuterol—NGF—Signaling by NGF—IL6—atopic dermatitis	6.95e-05	0.000867	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—CXCR3—atopic dermatitis	6.95e-05	0.000867	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CCL27—atopic dermatitis	6.92e-05	0.000863	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—TAC1—atopic dermatitis	6.89e-05	0.00086	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—NPS—atopic dermatitis	6.89e-05	0.00086	CbGpPWpGaD
Clenbuterol—ADRB1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	6.82e-05	0.000851	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—CXCR3—atopic dermatitis	6.76e-05	0.000843	CbGpPWpGaD
Clenbuterol—ADRB2—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	6.67e-05	0.000833	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—IL5—atopic dermatitis	6.65e-05	0.000829	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—IL1B—atopic dermatitis	6.61e-05	0.000825	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—atopic dermatitis	6.52e-05	0.000814	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—atopic dermatitis	6.5e-05	0.000811	CbGpPWpGaD
Clenbuterol—TNF—Selenium Micronutrient Network—IL6—atopic dermatitis	6.5e-05	0.00081	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	6.49e-05	0.000809	CbGpPWpGaD
Clenbuterol—TNF—Apoptosis—MAPK8—atopic dermatitis	6.47e-05	0.000807	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—IL5—atopic dermatitis	6.41e-05	0.0008	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	6.35e-05	0.000792	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CCL17—atopic dermatitis	6.34e-05	0.000792	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CCL17—atopic dermatitis	6.31e-05	0.000788	CbGpPWpGaD
Clenbuterol—TNF—TNF alpha Signaling Pathway—IL6—atopic dermatitis	6.27e-05	0.000782	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—TAC1—atopic dermatitis	6.26e-05	0.000781	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—NPS—atopic dermatitis	6.26e-05	0.000781	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CCL17—atopic dermatitis	6.21e-05	0.000774	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—CXCR3—atopic dermatitis	6.14e-05	0.000766	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—MAPK8—atopic dermatitis	6.06e-05	0.000757	CbGpPWpGaD
Clenbuterol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	5.95e-05	0.000743	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	5.84e-05	0.000729	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—IL5—atopic dermatitis	5.82e-05	0.000726	CbGpPWpGaD
Clenbuterol—TNF—Toll-like Receptor Signaling Pathway—IL6—atopic dermatitis	5.77e-05	0.00072	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—CXCL10—atopic dermatitis	5.74e-05	0.000716	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	5.72e-05	0.000713	CbGpPWpGaD
Clenbuterol—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARA—atopic dermatitis	5.68e-05	0.000708	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CXCL10—atopic dermatitis	5.67e-05	0.000707	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—KIF3A—atopic dermatitis	5.63e-05	0.000702	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—CXCL10—atopic dermatitis	5.61e-05	0.0007	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	5.47e-05	0.000683	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—CXCL10—atopic dermatitis	5.46e-05	0.000682	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—IL6—atopic dermatitis	5.14e-05	0.000641	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CCL11—atopic dermatitis	5.11e-05	0.000638	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CMA1—atopic dermatitis	5.09e-05	0.000635	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CCL11—atopic dermatitis	5.09e-05	0.000635	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—FCER2—atopic dermatitis	5.04e-05	0.000629	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CCL11—atopic dermatitis	5e-05	0.000624	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—CXCL10—atopic dermatitis	4.96e-05	0.000619	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—CCL5—atopic dermatitis	4.94e-05	0.000616	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—FCER2—atopic dermatitis	4.93e-05	0.000615	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CCL5—atopic dermatitis	4.88e-05	0.000609	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—CCL5—atopic dermatitis	4.83e-05	0.000603	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—STAT6—atopic dermatitis	4.79e-05	0.000597	CbGpPWpGaD
Clenbuterol—TNF—Adipogenesis—IL6—atopic dermatitis	4.75e-05	0.000593	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—atopic dermatitis	4.73e-05	0.000591	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—TNF—atopic dermatitis	4.73e-05	0.000591	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—CCL5—atopic dermatitis	4.7e-05	0.000587	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CCL22—atopic dermatitis	4.69e-05	0.000585	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—PPARA—atopic dermatitis	4.61e-05	0.000575	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—CCR3—atopic dermatitis	4.59e-05	0.000573	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CCL22—atopic dermatitis	4.59e-05	0.000572	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—CXCL8—atopic dermatitis	4.53e-05	0.000566	CbGpPWpGaD
Clenbuterol—TNF—Regulation of toll-like receptor signaling pathway—IL6—atopic dermatitis	4.51e-05	0.000562	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—CCR3—atopic dermatitis	4.49e-05	0.00056	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—CCR5—atopic dermatitis	4.45e-05	0.000555	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	4.44e-05	0.000554	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CCR5—atopic dermatitis	4.39e-05	0.000548	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—CCR5—atopic dermatitis	4.35e-05	0.000543	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—CCL5—atopic dermatitis	4.27e-05	0.000533	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—CCR5—atopic dermatitis	4.24e-05	0.000529	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CCL27—atopic dermatitis	4.18e-05	0.000521	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CCR3—atopic dermatitis	4.17e-05	0.00052	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CCR3—atopic dermatitis	4.15e-05	0.000518	CbGpPWpGaD
Clenbuterol—TNF—SIDS Susceptibility Pathways—IL6—atopic dermatitis	4.11e-05	0.000513	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—NPS—atopic dermatitis	4.09e-05	0.000511	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—TAC1—atopic dermatitis	4.09e-05	0.000511	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CCL27—atopic dermatitis	4.09e-05	0.00051	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CCR3—atopic dermatitis	4.08e-05	0.000509	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—CXCR3—atopic dermatitis	4.01e-05	0.000501	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—TAC1—atopic dermatitis	4e-05	0.000499	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—NPS—atopic dermatitis	4e-05	0.000499	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—CXCR3—atopic dermatitis	3.93e-05	0.00049	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—CCR5—atopic dermatitis	3.85e-05	0.00048	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—IL5—atopic dermatitis	3.8e-05	0.000475	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CCL17—atopic dermatitis	3.75e-05	0.000468	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—NFKBIA—atopic dermatitis	3.73e-05	0.000465	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—IL5—atopic dermatitis	3.72e-05	0.000464	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—NPS—atopic dermatitis	3.72e-05	0.000464	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—TAC1—atopic dermatitis	3.72e-05	0.000464	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—NPS—atopic dermatitis	3.7e-05	0.000461	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—TAC1—atopic dermatitis	3.7e-05	0.000461	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CCL17—atopic dermatitis	3.67e-05	0.000457	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CXCR3—atopic dermatitis	3.64e-05	0.000455	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—NPS—atopic dermatitis	3.63e-05	0.000453	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—TAC1—atopic dermatitis	3.63e-05	0.000453	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CXCR3—atopic dermatitis	3.63e-05	0.000452	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CXCR3—atopic dermatitis	3.56e-05	0.000445	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	3.53e-05	0.000441	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	3.46e-05	0.000431	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—IL5—atopic dermatitis	3.45e-05	0.000431	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—IL5—atopic dermatitis	3.44e-05	0.000429	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—IL5—atopic dermatitis	3.38e-05	0.000422	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—KIF3A—atopic dermatitis	3.34e-05	0.000417	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—KIF3A—atopic dermatitis	3.27e-05	0.000408	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—CXCL10—atopic dermatitis	3.24e-05	0.000405	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—CXCL10—atopic dermatitis	3.17e-05	0.000396	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GLB1—atopic dermatitis	3.1e-05	0.000387	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CCL11—atopic dermatitis	3.02e-05	0.000377	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CMA1—atopic dermatitis	3.02e-05	0.000377	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—ADSL—atopic dermatitis	2.97e-05	0.000371	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CCL11—atopic dermatitis	2.96e-05	0.000369	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CMA1—atopic dermatitis	2.96e-05	0.000369	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CXCL10—atopic dermatitis	2.95e-05	0.000367	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CXCL10—atopic dermatitis	2.93e-05	0.000366	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CXCL10—atopic dermatitis	2.88e-05	0.000359	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—STAT6—atopic dermatitis	2.84e-05	0.000354	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—CCL5—atopic dermatitis	2.79e-05	0.000348	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—STAT6—atopic dermatitis	2.78e-05	0.000347	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—CCL5—atopic dermatitis	2.73e-05	0.000341	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—CXCL8—atopic dermatitis	2.69e-05	0.000336	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CXCL8—atopic dermatitis	2.66e-05	0.000331	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—CXCL8—atopic dermatitis	2.63e-05	0.000328	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—CXCL8—atopic dermatitis	2.56e-05	0.00032	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—IL2—atopic dermatitis	2.54e-05	0.000317	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CCL5—atopic dermatitis	2.54e-05	0.000316	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CCL5—atopic dermatitis	2.52e-05	0.000315	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—CCR5—atopic dermatitis	2.52e-05	0.000314	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CCL5—atopic dermatitis	2.48e-05	0.000309	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CCR3—atopic dermatitis	2.46e-05	0.000307	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—CCR5—atopic dermatitis	2.46e-05	0.000307	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—IL2—atopic dermatitis	2.45e-05	0.000306	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CCR3—atopic dermatitis	2.41e-05	0.000301	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—MAPK8—atopic dermatitis	2.34e-05	0.000292	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—NGF—atopic dermatitis	2.34e-05	0.000292	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—CXCL8—atopic dermatitis	2.33e-05	0.00029	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CCR5—atopic dermatitis	2.28e-05	0.000285	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CCR5—atopic dermatitis	2.27e-05	0.000284	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	2.26e-05	0.000282	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CCR5—atopic dermatitis	2.23e-05	0.000279	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—IL2—atopic dermatitis	2.22e-05	0.000277	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—TAC1—atopic dermatitis	2.19e-05	0.000274	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—NPS—atopic dermatitis	2.19e-05	0.000274	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CXCR3—atopic dermatitis	2.15e-05	0.000269	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—TAC1—atopic dermatitis	2.15e-05	0.000268	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—NPS—atopic dermatitis	2.15e-05	0.000268	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CXCR3—atopic dermatitis	2.11e-05	0.000263	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—IL5—atopic dermatitis	2.04e-05	0.000255	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—IL5—atopic dermatitis	2e-05	0.000249	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GLB1—atopic dermatitis	1.98e-05	0.000247	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—NFKBIA—atopic dermatitis	1.93e-05	0.00024	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ADSL—atopic dermatitis	1.9e-05	0.000237	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CXCL10—atopic dermatitis	1.74e-05	0.000217	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CXCL10—atopic dermatitis	1.7e-05	0.000212	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—IL6—atopic dermatitis	1.63e-05	0.000204	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—CXCL8—atopic dermatitis	1.52e-05	0.00019	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CCL5—atopic dermatitis	1.5e-05	0.000187	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—IL6—atopic dermatitis	1.49e-05	0.000186	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—CXCL8—atopic dermatitis	1.49e-05	0.000186	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CCL5—atopic dermatitis	1.47e-05	0.000183	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—IL2—atopic dermatitis	1.45e-05	0.000181	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.44e-05	0.00018	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—IL2—atopic dermatitis	1.42e-05	0.000177	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—NGF—atopic dermatitis	1.39e-05	0.000173	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CXCL8—atopic dermatitis	1.38e-05	0.000172	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CXCL8—atopic dermatitis	1.37e-05	0.000171	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—NGF—atopic dermatitis	1.36e-05	0.000169	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CXCL8—atopic dermatitis	1.35e-05	0.000169	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CCR5—atopic dermatitis	1.35e-05	0.000168	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CCR5—atopic dermatitis	1.32e-05	0.000165	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—IL2—atopic dermatitis	1.32e-05	0.000165	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—IL2—atopic dermatitis	1.31e-05	0.000164	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—IL6—atopic dermatitis	1.31e-05	0.000163	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—IL2—atopic dermatitis	1.29e-05	0.000161	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MAPK8—atopic dermatitis	1.21e-05	0.000151	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—NFKBIA—atopic dermatitis	1.14e-05	0.000143	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—NFKBIA—atopic dermatitis	1.12e-05	0.00014	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PPARA—atopic dermatitis	1.01e-05	0.000126	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CXCL8—atopic dermatitis	8.16e-06	0.000102	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CXCL8—atopic dermatitis	7.98e-06	9.96e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—IL2—atopic dermatitis	7.8e-06	9.73e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—IL6—atopic dermatitis	7.76e-06	9.68e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—IL6—atopic dermatitis	7.72e-06	9.63e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—IL2—atopic dermatitis	7.63e-06	9.52e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—IL6—atopic dermatitis	7.59e-06	9.47e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MAPK8—atopic dermatitis	7.18e-06	8.95e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MAPK8—atopic dermatitis	7.02e-06	8.76e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PPARA—atopic dermatitis	6.42e-06	8.01e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—IL6—atopic dermatitis	4.58e-06	5.72e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—IL6—atopic dermatitis	4.48e-06	5.59e-05	CbGpPWpGaD
